Eduardo Lacson

TL;DR: In this article, the authors report seroresponse based on levels of immunoglobulin-G against the receptor binding domain of the S1 subunit of SARS-CoV-2 spike antigen using FDA-approved semi-quantitative chemiluminescent assay (ADVIA Centaur(R) XP/XPT COV2G).

TL;DR: Depressive symptoms reported within the first 90 days of dialysis were associated with greater dialysis withdrawal and mortality risk over the succeeding year, and further evaluation for and treatment of depression during this early vulnerable period may improve symptoms, increase survival and decrease premature withdrawal from dialysis.

TL;DR: Because of the higher mortality risk associated with low or “normal” BP, diagnostic and therapeutic options and strategies for ESRD patients whose BP falls within “goal” should be addressed in future iterations of clinical practice guidelines.

TL;DR: Depressive affect in incident hemodialysis patients was associated with higher risk of hospitalization and more hospital days, and future studies are needed to investigate the effect of therapeutic interventions to address depressive affect in this high-risk population.

TL;DR: Achieving more facility quality goals was significantly associated with better facility-based measurements of patient outcomes, and findings agree with the present practice of monitoring facility performance for continuous quality improvement.